MeSH D000224 - addison disease
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D000309:Adrenal insufficiency
D000224:
Addison disease
D000075262:Familial hypoadrenocorticism
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Dexamethasone | Dexamethasone | 1990-08-31 | |||
| Padagis | Dexamethasone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Dexamethasone | 1989-07-31 | |||
| Dexamethasone, Tobramycin | Tobramycin Dexamethasone | 2022-02-11 | ||||
| Mylan | Dexamethasone | Dexamethasone | 2008-08-29 | |||
| Sandoz | Dexamethasone | Dexamethasone | 1985-01-16 | |||
| Dexamethasone, Neomycin, Polymyxin b | Maxitrol | 1984-05-22 | ||||
| Dexamethasone, Ciprofloxacin | Ciprodex | 2025-06-04 | 2003-07-18 | |||
| Dexamethasone, Tobramycin | Tobradex | 1988-08-18 | ||||
| AbbVie | Dexamethasone | Ozurdex | 2023-01-09 | 2009-06-17 | $494 M | Y2024 |
| Novartis | Dexamethasone, Neomycin, Polymyxin b | Dexacidin | 1984-10-29 | |||
| Dexamethasone, Tobramycin | Tobradex | 1988-09-28 | ||||
| Wyeth | Dexamethasone | Dexamethasone | 1982-01-01 | |||
| UCB | Dexamethasone | Dexacort | 1982-01-01 | |||
| Alpharma | Dexamethasone | Dexamethasone | 1986-10-10 | |||
| Bausch Health Companies | Dexamethasone | Dexamethasone | 1996-07-26 | |||
| Dexamethasone, Neomycin, Polymyxin b | Dexasporin | 1995-09-13 | ||||
| Dexamethasone, Neomycin | Neomycin Dexamethasone | 1995-10-30 | ||||
| Dexamethasone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Dexamethasone | 1994-07-25 | ||||
| Dexamethasone, Tobramycin | Tobramycin Dexamethasone | 1999-10-27 |
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
100%6/6
Phase 2
100%6/6
Phase 3
56%5/9
Approved: 2Overall Success rate: 56%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use